|
1
|
Guo N, Zhou QB, Chen RF, Zou SQ, Li ZH,
Lin Q, Wang J and Chen JS: Diagnosis and surgical treatment of
solid pseudopapillary neoplasm of the pancreas: Analysis of 24
cases. Can J Surg. 54:368–374. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papavramidis T and Papavramidis S: Solid
pseudopapillary tumors of the pancreas: Review of 718 patients
reported in English literature. J Am Coll Surg. 200:965–972. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yagcı A, Yakan S, Coskun A, Erkan N,
Yıldırım M, Yalcın E and Postacı H: Diagnosis and treatment of
solid pseudopapillary tumor of the pancreas: Experience of one
single institution from Turkey. World J Surg Oncol. 11:3082013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JS, Han HJ, Choi SB, Jung CW, Song TJ
and Choi SY: Surgical outcomes of solid pseudopapillary neoplasm of
the pancreas: A single institution's experience for the last ten
years. Am Surg. 78:216–219. 2012.PubMed/NCBI
|
|
5
|
Ansari D, Elebro J, Tingstedt B, Ygland E,
Fabricius M, Andersson B and Andersson R: Single-institution
experience with solid pseudopapillary neoplasm of the pancreas.
Scand J Gastroenterol. 46:1492–1497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adams AL, Siegal GP and Jhala NC: Solid
pseudopapillary tumor of the pancreas: A review of salient clinical
and pathologic features. Adv Anat Pathol. 15:39–45. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang SC, Ng KF, Yeh TS, Chang HC, Su CY
and Chen TC: Clinicopathological analysis of β-catenin and Axin-1
in solid pseudopapillary neoplasms of the pancreas. Ann Surg Oncol.
19 Suppl 3:S438–S446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobayashi T, Ozasa M, Miyashita K, Saga A,
Miwa K, Saito M, Morioka M, Takeuchi M, Takenouchi N, Yabiku T, et
al: Large solid-pseudopapillary neoplasm of the pancreas with
aberrant protein expression and mutation of β-catenin: A case
report and literature review of the distribution of β-catenin
mutation. Intern Med. 52:2051–2056. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koesters R and von Knebel Doeberitz M: The
Wnt signaling pathway in solid childhood tumors. Cancer Lett.
198:123–138. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sangkhathat S, Kusafuka T, Miao J, Yoneda
A, Nara K, Yamamoto S, Kaneda Y and Fukuzawa M: In vitro RNA
interference against β-catenin inhibits the proliferation of
pediatric hepatic tumors. Int J Oncol. 28:715–722. 2006.PubMed/NCBI
|
|
12
|
Sangkhathat S, Kanngurn S, Chaiyapan W,
Gridist P and Maneechay W: Wilms' tumor 1 gene (WT1) is
overexpressed and provides an oncogenic function in pediatric
nephroblastomas harboring the wild-type WT1. Oncol Lett. 1:615–619.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Fageeh M, Li Q, Dashwood WM, Myzak MC
and Dashwood RH: Phosphorylation and ubiquitination of oncogenic
mutants of beta-catenin containing substitutions at Asp32.
Oncogene. 23:4839–4846. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Provost E, McCabe A, Stern J, Lizardi I,
D'Aquila TG and Rimm DL: Functional correlates of mutation of the
Asp32 and Gly34 residues of beta-catenin. Oncogene. 24:2667–2676.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koch A, Denkhaus D, Albrecht S, Leuschner
I, von Schweinitz D and Pietsch T: Childhood hepatoblastomas
frequently carry a mutated degradation targeting box of the
beta-catenin gene. Cancer Res. 59:269–273. 1999.PubMed/NCBI
|
|
16
|
Udatsu Y, Kusafuka T, Kuroda S, Miao J and
Okada A: High frequency of beta-catenin mutations in
hepatoblastoma. Pediatr Surg Int. 17:508–512. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wanitsuwan W, Kanngurn S,
Boonpipattanapong T, Sangthong R and Sangkhathat S: Overall
expression of beta-catenin outperforms its nuclear accumulation in
predicting outcomes of colorectal cancers. World J Gastroenterol.
14:6052–6059. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buchan DW, Minneci F, Nugent TC, Bryson K
and Jones DT: Scalable web services for the PSIPRED protein
analysis workbench. Nucleic Acids Res. 41:(Web Server issue).
W349–W357. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones DT: Protein secondary structure
prediction based on position-specific scoring matrices. J Mol Biol.
292:195–202. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Petersen B, Petersen TN, Andersen P,
Nielsen M and Lundegaard C: A generic method for assignment of
reliability scores applied to solvent accessibility predictions.
BMC Struct Biol. 9:512009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maupetit J, Derreumaux P and Tuffery P:
PEP-FOLD: An online resource for de novo peptide structure
prediction. Nucleic Acids Res. 37:(Web Server Issue). W498–W503.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maupetit J, Derreumaux P and Tufféry P: A
fast method for large-scale de novo peptide and miniprotein
structure prediction. J Comput Chem. 31:726–738. 2010.PubMed/NCBI
|
|
23
|
Thévenet P, Shen Y, Maupetit J, Guyon F,
Derreumaux P and Tufféry P: PEP-FOLD: An updated de novo structure
prediction server for both linear and disulfide bonded cyclic
peptides. Nucleic Acids Res. 40:(Web Server Issue). W288–W293.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Case DA, Cerutti DS, Cheatham TE III,
Darden TA, Duke RE, Giese TJ, Gohlke H, Goetz AW, Greene D, Homeyer
N, et al: AMBER 2017. University of California, SF; 2017
|
|
25
|
Pastor RW, Brooks BR and Szabo A: An
analysis of the accuracy of Langevin and molecular dynamics
algorithms. Mol Phys. 65:1409–1419. 1988. View Article : Google Scholar
|
|
26
|
Berendsen HJC, Postma JPM, Gunsteren WF,
van DiNola A and Haak JR: Molecular dynamics with coupling to an
external bath. J Chem Phys. 81:3684–3690. 1984. View Article : Google Scholar
|
|
27
|
Darden TA and Pedersen LG: Molecular
modeling: An experimental tool. Environ Health Perspect.
101:410–412. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Case DA, Darden TA, Cheatham TE III,
Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM,
et al: AMBER 12. University of California, SF; 2012
|
|
29
|
Humphrey W, Dalke A and Schulten K: VMD:
Visual molecular dynamics. J Mol Graph. 14(33–38): 27–28. 1996.
|
|
30
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chan EF, Gat U, McNiff JM and Fuchs E: A
common human skin tumour is caused by activating mutations in
beta-catenin. Nat Genet. 21:410–413. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Legoix P, Bluteau O, Bayer J, Perret C,
Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P and
Zucman-Rossi J: Beta-catenin mutations in hepatocellular carcinoma
correlate with a low rate of loss of heterozygosity. Oncogene.
18:4044–4046. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang H, Mahler-Araujo BM, Sankila A,
Chimelli L, Yonekawa Y, Kleihues P and Ohgaki H: APC mutations in
sporadic medulloblastomas. Am J Pathol. 156:433–437. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
van Noort M, van de Wetering M and Clevers
H: Identification of two novel regulated serines in the N terminus
of beta-catenin. Exp Cell Res. 276:264–272. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koesters R, Ridder R, Kopp-Schneider A,
Betts D, Adams V, Niggli F, Briner J and von Knebel Doeberitz M:
Mutational activation of the beta-catenin proto-oncogene is a
common event in the development of Wilms' tumors. Cancer Res.
59:3880–3882. 1999.PubMed/NCBI
|
|
36
|
Ellison DW, Onilude OE, Lindsey JC, Lusher
ME, Weston CL, Taylor RE, Pearson AD and Clifford SC: United
Kingdom Children's Cancer Study Group Brain Tumour Committee:
beta-Catenin status predicts a favorable outcome in childhood
medulloblastoma: The United Kingdom Children's Cancer Study Group
Brain Tumour Committee. J Clin Oncol. 23:7951–7957. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chmara M, Wernstedt A, Wasag B, Peeters H,
Renard M, Beert E, Brems H, Giner T, Bieber I, Hamm H, et al:
Multiple pilomatricomas with somatic CTNNB1 mutations in children
with constitutive mismatch repair deficiency. Genes Chromosomes
Cancer. 52:656–664. 2013.PubMed/NCBI
|
|
38
|
Silva RD, Marie SK, Uno M, Matushita H,
Wakamatsu A, Rosemberg S and Oba-Shinjo SM: CTNNB1, AXIN1 and APC
expression analysis of different medulloblastoma variants. Clinics
(Sao Paulo). 68:167–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
